Angeles Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Sep 22 US 12,742,152 Diverse Antigen Binding Domains, Novel Platforms and Other Enhancements for Cellular Therapy
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,415,987 | Methods and composition for producing and using immune cells and stem cells for cell-based therapies In force · USPTO record | In force | USPTO record | |
| US 11,382,931 | Methods and Composition for Producing and Using Immune Cells and Stem Cells for Cell-Based Therapies In force · High confidence | In force | High confidence | |
| US 12,269,859 | Synthetic Immune Receptors and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 12,570,711 | Novel Platforms for Co-Stimulation, Novel Car Designs and Other Enhancements for Adoptive Cellular Therapy In force · High confidence | In force | High confidence | |
| US 12,305,186 | Methods for expanding SARS-COV2-antigen-specific t cells, compositions and uses related thereto In force · USPTO record | In force | USPTO record | |
| US 12,742,152 | Diverse Antigen Binding Domains, Novel Platforms and Other Enhancements for Cellular Therapy In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending